FindTrial
Sign In

Epidemiological Study of Dry Eye Disease in Stavanger: Dry Eye Disease in Patients Treated With Intravitreal Injections

Epidemiological Study of Dry Eye Disease in Stavanger: Dry Eye Disease in Patients With Age-related Macular Degeneration Treated With Intravitreal Injections

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04458012
Acronym
EPISTA1
Enrollment
300
Registered
2020-07-07
Start date
2020-06-25
Completion date
2024-06-30
Last updated
2020-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Brief summary

To investigate prevalence of dry eye disease in Norwegian patients with age-related macular degeneration receiving intravitreal injections, as well as to reveal possible risk factors of DED in this population.

Detailed description

Questionaires (OSDI, McMonnies) and clinical investigation using the Oculus 5 Keratograph for objective ocular surface evaluation. Tear fluid samples will be collected for later biochemical analysis.

Interventions

DIAGNOSTIC_TESTOculus Keratograph. Schirmer test. Tear fluid sample.

Objective measurements of the ocular surface using Oculus 5 keratograph. Slit lamp examination and tear fluid sample using Schirmer strips.

Sponsors

Tor Paaske Utheim
CollaboratorUNKNOWN
Vegard Asgeir Forsaa
CollaboratorUNKNOWN
Vilde Marie Thomseth
CollaboratorUNKNOWN
Helse Stavanger HF
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* AMD diagnosis * Treated with intravitreal injection agents

Exclusion criteria

* Not able to cooperate

Design outcomes

Primary

MeasureTime frame
Dry eye disease in patients receiving intravitreal injections2022

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 19, 2026